학술논문

A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)
Document Type
Journal
Source
CANCER RESEARCH; FEB 15 2022, 82 4, 3p. Supplement: S
Subject
Language
English
ISSN
15387445